Faculty
Fadia T. Shaya PhD, MPH
Associate Director, Center on Drugs and Public Policy
 Associate Professor220 Arch Street, Room 01-204 Baltimore, MD 21201 410-706-5392 - phone 410-706-5394 - fax fshaya@rx.umaryland.edu Faculty Web Site |
Fadia T. Shaya PhD, MPH, is Associate Professor, in Outcomes Research at the University of Maryland School of Pharmacy, and in Epidemiology and Preventive Medicine at the University of Maryland School of Medicine. Dr. Shaya is Associate Director for the Center on Drugs and Public Policy in the Department of Pharmaceutical Health Services Research.
Dr. Shaya has experience in developing clinical, economic, decision analysis and budget impact models. Her expertise is in formulary management and managed care issues. Dr. Shaya is a member of the P&T committee at CareFirst BlueCross BlueShield, and a member of the Editorial Advisory Boards for JMCP and Expert Review of Pharmacoeconomics and Outcomes Research. She serves as a reviewer for and has published in a number of peer-reviewed journals, including Health Affairs and Archives of Internal Medicine. Her current research focuses on survival analysis, propensity scores modeling and applications to formulary decision-making. She is working in therapeutic areas of cardiovascular and respiratory diseases, oncology, and ophthalmology. She is the recipient (CO-Principal Investigator) on a $6 Million five year grant from the National Heart, Lung, and Blood Institute (NHLBI) (PI: Dr. Elijah Saunders), to establish partnerships to reduce cardiovascular disparities. She has experience analyzing and handling large claims data sets, and designing retrospective as well as prospective studies.
Currently Dr. Shaya is working with commercial and Medicaid managed care organizations formulary committees, to apply pharmacoeconomic tools to information presented for coverage decisions. She also serves as the Chair of the Governor’s Advisory Council on Hepatitis C and Diseases of the Liver, for the State of Maryland.
Dr. Shaya obtained her PhD from the Johns Hopkins Bloomberg School of Public Health, her masters from the Sorbonne University Paris-IX, and completed a post-doctoral fellowship in pharmacoeconomics and formulary management at the University of Maryland School of Pharmacy and CareFirst BlueCross BlueShield. For two consecutive years, she received the Drug Information doctoral award from the US Pharmacopeia. Prior to that, she worked in research on health care financing issues at the Health Planning Commission in Paris, France.